Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 Apr 2022
Historique:
received: 09 11 2021
revised: 05 01 2022
accepted: 19 01 2022
pubmed: 26 1 2022
medline: 15 3 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

The prognostic value of change in six-minute walking distance (6MWD) after treatment to predict mortality in heart failure (HF) remains a controversial issue. We assessed the prognostic value of rehabilitation-induced improvement in 6MWD in predicting mortality in patients with HF. We studied 2257 patients admitted to six inpatient rehabilitation facilities after a hospitalization for HF (N. 912) or because of worsening functional capacity and/or deteriorating clinical status (N. 1345). A six-minute walking test was performed at admission and discharge. The primary outcome was 3-year all-cause mortality after discharge from cardiac rehabilitation. We used multivariable Cox proportional hazard modeling to assess the association of increase in 6MWD with 3-year mortality, adjusting for established predictors of mortality. 6MWD significantly increased by 61 m (p < .001) from admission to discharge and 969 patients (42.9%) achieved an increase in 6MWD >50 m. After full adjustment, an increase in 6MWD >50 m was associated with a 22% decreased risk for 3-year mortality (HR 0.78 [95% CI 0.68-0.91]; p = .002). When modeled as a continuous variable, improvement in 6MWD remained independently associated with decreased risk for 3-year mortality (HR per each 50 m increase: 0.92 [95% CI 0.88-0.96]). Rehabilitation-induced improvement in 6MWD was associated with a significantly reduced risk for 3-year mortality. Our data also suggest that an improvement in 6MWD of more than 50 m could represent a clinically meaningful endpoint of cardiac rehabilitation for patients with heart failure.

Sections du résumé

BACKGROUND BACKGROUND
The prognostic value of change in six-minute walking distance (6MWD) after treatment to predict mortality in heart failure (HF) remains a controversial issue. We assessed the prognostic value of rehabilitation-induced improvement in 6MWD in predicting mortality in patients with HF.
METHODS METHODS
We studied 2257 patients admitted to six inpatient rehabilitation facilities after a hospitalization for HF (N. 912) or because of worsening functional capacity and/or deteriorating clinical status (N. 1345). A six-minute walking test was performed at admission and discharge. The primary outcome was 3-year all-cause mortality after discharge from cardiac rehabilitation. We used multivariable Cox proportional hazard modeling to assess the association of increase in 6MWD with 3-year mortality, adjusting for established predictors of mortality.
RESULTS RESULTS
6MWD significantly increased by 61 m (p < .001) from admission to discharge and 969 patients (42.9%) achieved an increase in 6MWD >50 m. After full adjustment, an increase in 6MWD >50 m was associated with a 22% decreased risk for 3-year mortality (HR 0.78 [95% CI 0.68-0.91]; p = .002). When modeled as a continuous variable, improvement in 6MWD remained independently associated with decreased risk for 3-year mortality (HR per each 50 m increase: 0.92 [95% CI 0.88-0.96]).
CONCLUSIONS CONCLUSIONS
Rehabilitation-induced improvement in 6MWD was associated with a significantly reduced risk for 3-year mortality. Our data also suggest that an improvement in 6MWD of more than 50 m could represent a clinically meaningful endpoint of cardiac rehabilitation for patients with heart failure.

Identifiants

pubmed: 35074489
pii: S0167-5273(22)00129-2
doi: 10.1016/j.ijcard.2022.01.040
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-97

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Domenico Scrutinio (D)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari (Bari), Italy. Electronic address: domenico.scrutinio@icsmaugeri.it.

Pietro Guida (P)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari (Bari), Italy.

Andrea Passantino (A)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Bari (Bari), Italy.

Simonetta Scalvini (S)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Lumezzane (Brescia), Italy.

Maurizio Bussotti (M)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Milano-Camaldoli (Milano), Italy.

Giovanni Forni (G)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Pavia (Pavia), Italy.

Valentina Tibollo (V)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Pavia (Pavia), Italy.

Raffaella Vaninetti (R)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Tradate (Varese), Italy.

Maria Teresa La Rovere (MT)

Istituti Clinici Scientifici Maugeri SpA SB, IRCCS, Institute of Montescano (Pavia), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH